Keynote Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
6,389
-49
-0.8% -$17.5K 1.2% 18
2025
Q4
$2.11M Sell
6,438
-13
-0.2% -$4.12K 1.18% 18
2025
Q3
$1.82M Buy
6,451
+1,031
+19% +$299K 1.1% 21
2025
Q2
$1.51M Buy
5,420
+593
+12% +$168K 1.02% 24
2025
Q1
$1.5M Buy
4,827
+61
+1% +$18K 1.07% 26
2024
Q4
$1.24M Buy
4,766
+108
+2% +$32K 0.95% 28
2024
Q3
$1.5M Sell
4,658
-240
-5% -$78.5K 1.15% 22
2024
Q2
$1.53M Buy
4,898
+30
+0.6% +$8.81K 1.28% 19
2024
Q1
$1.38M Buy
+4,868
New +$1.42M 1.16% 24

Other funds holding AMGN

Keynote Financial Services's AMGN Position: Q1 2026 in Review

Keynote Financial Services reduced its Amgen (AMGN) stake by 0.76% in Q1 2026, selling an estimated $17.5K and leaving 6,389 shares worth $2.25M. The position accounts for 1.2% of the portfolio, ranked #18.

Keynote Financial Services first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Keynote Financial Services held 6,389 shares of Amgen worth $2.25M as of Q1 2026.
  • Keynote Financial Services sold 49 Amgen shares in Q1 2026, an estimated $17.5K.
  • Amgen made up 1.2% of Keynote Financial Services's portfolio in Q1 2026, its #18 holding.
  • Keynote Financial Services first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.